Table 4.
Relation between psoriasis duration and sleep quality in studied cases.
| PSQI components | Disease duration/years Median (min–max) |
Test of significance |
|---|---|---|
| Subjective sleep quality | ||
| 0 | 6 (1–30) |
KW = 12.6 p = 0.002* |
| 1 | 10 (3–30) | |
| 2 | 9.5 (2–12) | |
| Sleep latency | ||
| 0 | 6 (1–30) |
KW = 16.79 p = 0.001* |
| 1 | 7 (1–20) | |
| 2 | 9 (3–30) | |
| 3 | 11 (1–20) | |
| Sleep duration | ||
| 0 | 7 (1–20) |
KW = 10.0 p = 0.019* |
| 1 | 9 (1–30) | |
| 2 | 11.5 (7–16) | |
| 3 | 17 (17–17) | |
| Sleep efficiency | ||
| 0 | 7 (1–30) |
KW = 8.61 p = 0.035* |
| 1 | 9 (1–20) | |
| 2 | 12 (2–18) | |
| 3 | 3 (3–3) | |
| Sleep disturbance | ||
| 0 | 7 (1–20) |
KW = 6.88 p = 0.032* |
| 1 | 8 (1–30) | |
| 2 | 9 (4–10) | |
| Day time dysfunction | ||
| 0 | 7 (1–30) |
KW = 6.49 p = 0.039* |
| 1 | 10 (1–17) | |
| 2 | 9 (9–9) | |
| Global score | ||
| Good sleep ≤ 5 | 6.5 (1–30) |
Z = 3.41 p = 0.001* |
| Poor sleep > 5 | 10 (2–18) | |
KW Kruskal Wallis test, Z Mann Whitney U test, PSQI Pittsburgh sleep quality index.
*Statistically significant.